88493580

Information

• Trademark
• 88493580

• Source

• Serial Number

  88493580

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  June 28, 2019
  5 years ago

• Transaction Date

  August 02, 2021
  3 years ago

• Status Date

  August 02, 2021
  3 years ago

• Published for Opposition Date

  May 05, 2020
  4 years ago

• Location Date

  June 30, 2020
  4 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  CARROLL, DORITT

• Attorney Docket Number

  142802-003

  Attorney Name

  Glenn A. Gundersen

  Law Office Assigned Location Code

  M70

• Owners

  • Navitor Pharmaceuticals, Inc.

Case File Statements

• CC0000: The color(s) green and purple is/are claimed as a feature of the mark.
• DM0000: The mark consists of a spiral design composed of a green incomplete circle and purple gradient dots.
• GS0051: Pharmaceutical preparations and substances for the prevention, treatment and diagnosis of cancer, diabetes, and heart disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, and Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of immune disorders, namely, psoriasis, rheumatoid arthritis, lupus, Chron's disease, inflammatory bowel disease, and multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of metabolic, endocrine, cardiovascular, oncological, gastrointestinal, musculoskeletal, mitochondrial, autoimmune, and neurological related diseases and disorders; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of rare genetic diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of Leigh's syndrome, Friedrich's ataxia, lymphangioleiomyomatosis (LAM) and tuberous sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of obesity and obesity related diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of age-related diseases; pharmaceutical preparations and substances for modulating the catabolic or anabolic response to nutrients; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of any disease related to muscle wasting diseases and conditions, including, cachexia, sarcopenia and muscle wasting due to prolonged immobilization; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting caloric intake and absorption; nutraceuticals for use as dietary supplements; dietetic foods adapted for medical use; nutritional supplements containing amino acids; pharmaceutical preparations and substances for the modulation of appetite, namely, appetite suppressants and satiety inducers

Case File Event Statements

• 8/2/2021 - 3 years ago

  28 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 8/2/2021 - 3 years ago

  27 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 12/25/2020 - 4 years ago

  26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/23/2020 - 4 years ago

  25 - EXTENSION 1 GRANTED Type: EX1G

• 12/23/2020 - 4 years ago

  24 - EXTENSION 1 FILED Type: EXT1

• 12/23/2020 - 4 years ago

  23 - TEAS EXTENSION RECEIVED Type: EEXT

• 6/30/2020 - 4 years ago

  22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 5/5/2020 - 4 years ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/5/2020 - 4 years ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/15/2020 - 4 years ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/26/2020 - 4 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/26/2020 - 4 years ago

  17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/26/2020 - 4 years ago

  16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/26/2020 - 4 years ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/26/2020 - 4 years ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/19/2020 - 4 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/19/2020 - 4 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/19/2020 - 4 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/19/2019 - 5 years ago

  10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/19/2019 - 5 years ago

  9 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/19/2019 - 5 years ago

  8 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/18/2019 - 5 years ago

  7 - ASSIGNED TO EXAMINER Type: DOCK

• 7/10/2019 - 5 years ago

  6 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 7/10/2019 - 5 years ago

  5 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 7/9/2019 - 5 years ago

  4 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 7/8/2019 - 5 years ago

  3 - ASSIGNED TO LIE Type: ALIE

• 7/2/2019 - 5 years ago

  2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 7/2/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP